Login / Signup

Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.

Masaaki NishiMistuo ShimadaTakuya TokunagaJun HigashijimaKozo YoshikawaHideya KashiharaChie TakasuDaichi IshikawaYuma WadaShohei EtoToshiaki Yoshimoto
Published in: World journal of surgical oncology (2021)
Post-CRT LCR could be a prognostic biomarker for patients with lower rectal cancer.
Keyphrases
  • rectal cancer
  • locally advanced
  • peripheral blood
  • squamous cell carcinoma
  • cardiac resynchronization therapy